Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

Authors:

Abstract
No abstract available
Funding Information
  • European Commission Seventh Framework Programme (305404)
  • Care-for-Rare Foundation, Eva Luise und Horst Köhler Stiftung and REGISTRY WAREHOUSE (777295)

This publication has 34 references indexed in Scilit: